摘要
目的评价替考拉宁治疗重症监护病房(ICU)革兰阳性菌所致重症感染的临床疗效及安全性。方法共完成30例临床病例观察,替考拉宁400mg加入生理盐水250ml中静脉滴注,1次/24h,疗程7~10d。结果30例病例观察痊愈率为70.oo%,有效率为83.33%,细菌清除率为86.67%,不良反应发生率为6.67%。结论调查结果表明替考拉宁治疗革兰阳性菌所致重症感染是安全、有效的。
OBJECTIVE To evaluate the efficacy and safety of teieoplanin on the patients with severe infection in ICU. METHODS Thirty cases were observed and the dosage of drug was 400mg once a day for injection. The duration of the treatment was 7-10 days. RESULTS The total cure rate was 70. 0%, the total response was 83.33%, and the bacterial clearance rate was 86.67%. CONCLUSIONS Teicoplanin is both effective and safe for patients with severe infection in ICU.
出处
《中华医院感染学杂志》
CAS
CSCD
北大核心
2010年第1期93-94,共2页
Chinese Journal of Nosocomiology